EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation and analysis of clinical rational drug use under the DRGs/DIP payment model: a quasi-experimental study

Song Zhang, Yuanyuan Pu, Nanping Xiao, Yue Zhao, Hanjun He, Gang Ma

Journal of Global Health Economics and Policy · 27.03.2026 · 6

DOI: 10.7189/001c.159360 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Global Health Economics and Policy, online erschienen am 27.03.2026. Verfasst von Song Zhang und 5 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Diagnosis-Related Groups (DRGs) and Diagnosis-Intervention Packet (DIP) payment models aim to enhance healthcare efficiency, yet primary hospitals struggle with rational drug use under cost-control pressures. Pharmaceutical information management systems (PIMS) offer a potential solution, yet evidence from resource-limited settings remains limited. We evaluated whether a multifaceted intervention incorporating PIMS can improve drug use rationality and financial performance under DRGs/DIP in a primary hospital setting.

Methods

A quasi-experimental study with historical controls compared pre-intervention (January-December 2022) and post-intervention (January-December 2023) data from a primary hospital in Sichuan Province, China. The intervention comprised multidisciplinary team coordination, real-time clinical decision support, pharmacist-led ward rounds, training programs, and clinical pathway optimization. Outcomes included drug costs, antimicrobial use intensity (defined daily doses [DDD]/100 bed-days), prescription rationality rates, and DRG financial balance. Due to data aggregation at the hospital level, segmented regression analysis was not feasible; independent t-tests were used for pre-post comparisons.

Results

Post-intervention, average outpatient drug costs decreased significantly (33.48±3.67 vs. 39.29±5.52 yuan, p=0.006), and inpatient antimicrobial use intensity declined from 48.97±6.02 to 43.71±3.06 DDD/100 bed-days (p=0.013). Prescription review compliance improved from 93.67% to 97.50% (p

Zitieren

APA

Zhang, S., Pu, Y., Xiao, N., Zhao, Y., He, H., & Ma, G. (2026). Evaluation and analysis of clinical rational drug use under the DRGs/DIP payment model: a quasi-experimental study. Journal of Global Health Economics and Policy, 6. https://doi.org/10.7189/001c.159360

Vancouver

Zhang S, Pu Y, Xiao N, Zhao Y, He H, Ma G. Evaluation and analysis of clinical rational drug use under the DRGs/DIP payment model: a quasi-experimental study. Journal of Global Health Economics and Policy. 2026;6. doi:10.7189/001c.159360

BibTeX
@article{Zhang2026,
  author = {Zhang, Song and Pu, Yuanyuan and Xiao, Nanping and Zhao, Yue and He, Hanjun and Ma, Gang},
  title = {Evaluation and analysis of clinical rational drug use under the DRGs/DIP payment model: a quasi-experimental study},
  journal = {Journal of Global Health Economics and Policy},
  year = {2026},
  volume = {6},
  doi = {10.7189/001c.159360}
}
Kostenlos starten →